E7409
EPHA3 (571-end), active, GST tagged human
PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution
Synonym(s):
ETK, HEK, TYRO4
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 μg | Please contact Customer Service for Availability | PLN 1,860.00 |
About This Item
NACRES:
NA.32
UNSPSC Code:
51111800
Specific activity:
87-120 nmol/min·mg
Assay:
≥70% (SDS-PAGE)
Recombinant:
expressed in baculovirus infected Sf9 cells
1 of 1
This Item | |||
|---|---|---|---|
| specific activity 87-120 nmol/min·mg | specific activity 22-30 nmol/min·mg | specific activity 24-32 nmol/min·mg | specific activity 30-40 nmol/min·mg |
| assay ≥70% (SDS-PAGE) | assay ≥70% (SDS-PAGE) | assay ≥70% (SDS-PAGE) | assay ≥70% (SDS-PAGE) |
| Gene Information human ... EPHA3(2042) | Gene Information human ... EPHB3(2049) | Gene Information human ... EPHA1(2041) | Gene Information mouse ... Epha7(13841) |
| form buffered aqueous glycerol solution | form buffered aqueous glycerol solution | form buffered aqueous glycerol solution | form buffered aqueous glycerol solution |
| shipped in dry ice | shipped in dry ice | shipped in dry ice | shipped in dry ice |
| recombinant expressed in baculovirus infected Sf9 cells | recombinant expressed in baculovirus infected Sf9 cells | recombinant expressed in baculovirus infected Sf9 cells | recombinant expressed in baculovirus infected Sf9 cells |
General description
EPHA3 is a receptor tyrosine kinase (RTK) belonging to the largest subgroup of RTKs called ephrin group of receptors. It has a high level of expression from placental stage through the whole developmental process.[1] It is a type I transmembrane protein, and has a membrane-bound ligand. It is both an oncogene and a tumor-suppressor gene.[2][3] This protein resides in both the cytosol and the plasma membrane.[4]
Biochem/physiol Actions
EPHA3 binds the ephrin-A ligand and has diverse cellular function. Analysis of human colorectal, breast, lung and pancreatic cancer samples shows somatic mutations in the EPHA3 gene.[5] EPHA3 gene expression can be regulated by CD28 and IGF-1 in Jurkat cells and expression of EPHA3 is associated with adherence and motility of malignant T cells.[6] It maintains the less differentiated state of cancer cells, by activating MAPK (mitogen-activated protein kinase) pathway. It is over-expressed in glioblastoma (GBM) cells, especially during the initial stages. It also has higher expression levels in aggressive mesenchymal subtype of GBM.[7] In hepatocellular carcinoma (HCC), it predicts increased invasiveness and poor patient prognosis.[4]
Physical form
Supplied in 50 mM Tris-HCl, pH 7.5, with 150 mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol.
Legal Information
PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cheng-Yi Lu et al.
Oncology reports, 30(5), 2179-2186 (2013-08-24)
Although EphA3 expression has been associated with progression or prognosis in several types of tumors, the role of EphA3 in hepatocellular carcinoma (HCC) remains unknown. This study sought to investigate the clinicopathological and prognostic relevance of EphA3 expression in HCC
Jenni Lahtela et al.
Cell cycle (Georgetown, Tex.), 12(4), 625-634 (2013-01-18)
Activation of a cellular senescence program is a common response to prolonged oncogene activation or tumor suppressor loss, providing a physiological mechanism for tumor suppression in premalignant cells. The link between senescence and tumor suppression supports the hypothesis that a
Loraine M Smith et al.
Experimental cell research, 292(2), 295-303 (2003-12-31)
Stimulation of CD28 alone has been shown to regulate cytokine gene transcription and expression of the type 1 insulin-like growth factor receptor (IGF-1R) in lymphocytes. In this study, the ephrin receptor tyrosine kinase ephA3, was identified as a new CD28-responsive
Bryan W Day et al.
Cancer cell, 23(2), 238-248 (2013-02-16)
Significant endeavor has been applied to identify functional therapeutic targets in glioblastoma (GBM) to halt the growth of this aggressive cancer. We show that the receptor tyrosine kinase EphA3 is frequently overexpressed in GBM and, in particular, in the most
Structural recognition of an optimized substrate for the ephrin family of receptor tyrosine kinases.
Tara L Davis et al.
The FEBS journal, 276(16), 4395-4404 (2009-08-15)
Ephrin receptor tyrosine kinase A3 (EphA3, EC 2.7.10.1) is a member of a unique branch of the kinome in which downstream signaling occurs in both ligand- and receptor-expressing cells. Consequently, the ephrins and ephrin receptor tyrosine kinases often mediate processes
Related Content
Instructions
Instructions
Global Trade Item Number
| SKU | GTIN |
|---|---|
| E7409-10UG | 04061832850009 |
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service